Impact of preoperative NAFLD status on restoration of pancreatic β-cell function after laparoscopic sleeve gastrectomy
In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent laparoscopic sleeve gastrectomy. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell...
Saved in:
Published in | American journal of physiology: endocrinology and metabolism Vol. 328; no. 6; pp. E1013 - E1020 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Physiological Society
01.06.2025
|
Subjects | |
Online Access | Get full text |
ISSN | 0193-1849 1522-1555 1522-1555 |
DOI | 10.1152/ajpendo.00484.2024 |
Cover
Loading…
Abstract | In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent laparoscopic sleeve gastrectomy. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. Considering that amelioration of pancreatic beta-cell function leads to better outcome of T2D, the finding of this association would be clinically significant.
Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the mechanism and preoperative factors related to this amelioration have been uncertain. This study investigated the effect of laparoscopic sleeve gastrectomy (LSG) on beta-cell function. The preoperative characteristics and factors associated with the degree of postoperative changes in beta-cell function in those subjects were explored as well. In this subanalysis of our prospective observational study, subjects with obesity and T2D underwent oral glucose tolerance tests (OGTTs) and magnetic resonance imaging (MRI), at the baseline and the end of the 1-year follow-up period. Beta-cell function was evaluated by the insulin secretion-sensitivity index-2 (ISSI-2) and disposition index (DI), and the preoperative factors associated with these changes were examined. In 18 eligible subjects, glucose tolerance improved, ISSI-2 increased significantly, and DI also tended to increase 1 year after LSG. The change in ISSI-2 correlated with preoperative liver fibrosis assessed by MR elastography ( r = −0.49, P < 0.05). In 16 subjects without severe fibrosis, changes in DI correlated with preoperative MRI-estimated proton density fat fraction ( r = −0.52, P < 0.05). Neither as glycemic control nor visceral fat was significantly associated with the degree of amelioration in beta-cell function. Pancreatic beta-cell function improved at 1-year postoperative to LSG in subjects with obesity and T2D. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement.
NEW & NOTEWORTHY In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent laparoscopic sleeve gastrectomy. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. Considering that amelioration of pancreatic beta-cell function leads to better outcome of T2D, the finding of this association would be clinically significant. |
---|---|
AbstractList | In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent laparoscopic sleeve gastrectomy. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. Considering that amelioration of pancreatic beta-cell function leads to better outcome of T2D, the finding of this association would be clinically significant.
Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the mechanism and preoperative factors related to this amelioration have been uncertain. This study investigated the effect of laparoscopic sleeve gastrectomy (LSG) on beta-cell function. The preoperative characteristics and factors associated with the degree of postoperative changes in beta-cell function in those subjects were explored as well. In this subanalysis of our prospective observational study, subjects with obesity and T2D underwent oral glucose tolerance tests (OGTTs) and magnetic resonance imaging (MRI), at the baseline and the end of the 1-year follow-up period. Beta-cell function was evaluated by the insulin secretion-sensitivity index-2 (ISSI-2) and disposition index (DI), and the preoperative factors associated with these changes were examined. In 18 eligible subjects, glucose tolerance improved, ISSI-2 increased significantly, and DI also tended to increase 1 year after LSG. The change in ISSI-2 correlated with preoperative liver fibrosis assessed by MR elastography ( r = −0.49, P < 0.05). In 16 subjects without severe fibrosis, changes in DI correlated with preoperative MRI-estimated proton density fat fraction ( r = −0.52, P < 0.05). Neither as glycemic control nor visceral fat was significantly associated with the degree of amelioration in beta-cell function. Pancreatic beta-cell function improved at 1-year postoperative to LSG in subjects with obesity and T2D. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement.
NEW & NOTEWORTHY In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent laparoscopic sleeve gastrectomy. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. Considering that amelioration of pancreatic beta-cell function leads to better outcome of T2D, the finding of this association would be clinically significant. Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the mechanism and preoperative factors related to this amelioration have been uncertain. This study investigated the effect of laparoscopic sleeve gastrectomy (LSG) on beta-cell function. The preoperative characteristics and factors associated with the degree of postoperative changes in beta-cell function in those subjects were explored as well. In this sub-analysis of our prospective observational study, subjects with obesity and T2D underwent oral glucose tolerance tests (OGTT) and magnetic resonance imaging (MRI), at the baseline and the end of the 1-year follow-up period. Beta-cell function was evaluated by the insulin secretion-sensitivity index-2 (ISSI-2) and disposition index (DI), and the preoperative factors associated with these changes were examined. In 18 eligible subjects, glucose tolerance improved, ISSI-2 increased significantly, and DI also tended to increase 1 year after LSG. The change in ISSI-2 correlated with preoperative liver fibrosis assessed by MR elastography (r=-0.49, P<0.05). In 16 subjects without severe fibrosis, changes in DI correlated with preoperative MRI-estimated proton density fat fraction (r=-0.52, P<0.05). Neither as glycemic control nor visceral fat were significantly associated with the degree of amelioration in beta-cell function. Pancreatic beta-cell function improved at 1 year postoperative to LSG in subjects with obesity and T2D. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement.Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the mechanism and preoperative factors related to this amelioration have been uncertain. This study investigated the effect of laparoscopic sleeve gastrectomy (LSG) on beta-cell function. The preoperative characteristics and factors associated with the degree of postoperative changes in beta-cell function in those subjects were explored as well. In this sub-analysis of our prospective observational study, subjects with obesity and T2D underwent oral glucose tolerance tests (OGTT) and magnetic resonance imaging (MRI), at the baseline and the end of the 1-year follow-up period. Beta-cell function was evaluated by the insulin secretion-sensitivity index-2 (ISSI-2) and disposition index (DI), and the preoperative factors associated with these changes were examined. In 18 eligible subjects, glucose tolerance improved, ISSI-2 increased significantly, and DI also tended to increase 1 year after LSG. The change in ISSI-2 correlated with preoperative liver fibrosis assessed by MR elastography (r=-0.49, P<0.05). In 16 subjects without severe fibrosis, changes in DI correlated with preoperative MRI-estimated proton density fat fraction (r=-0.52, P<0.05). Neither as glycemic control nor visceral fat were significantly associated with the degree of amelioration in beta-cell function. Pancreatic beta-cell function improved at 1 year postoperative to LSG in subjects with obesity and T2D. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the mechanism and preoperative factors related to this amelioration have been uncertain. This study investigated the effect of laparoscopic sleeve gastrectomy (LSG) on beta-cell function. The preoperative characteristics and factors associated with the degree of postoperative changes in beta-cell function in those subjects were explored as well. In this subanalysis of our prospective observational study, subjects with obesity and T2D underwent oral glucose tolerance tests (OGTTs) and magnetic resonance imaging (MRI), at the baseline and the end of the 1-year follow-up period. Beta-cell function was evaluated by the insulin secretion-sensitivity index-2 (ISSI-2) and disposition index (DI), and the preoperative factors associated with these changes were examined. In 18 eligible subjects, glucose tolerance improved, ISSI-2 increased significantly, and DI also tended to increase 1 year after LSG. The change in ISSI-2 correlated with preoperative liver fibrosis assessed by MR elastography (r = −0.49, P < 0.05). In 16 subjects without severe fibrosis, changes in DI correlated with preoperative MRI-estimated proton density fat fraction (r = −0.52, P < 0.05). Neither as glycemic control nor visceral fat was significantly associated with the degree of amelioration in beta-cell function. Pancreatic beta-cell function improved at 1-year postoperative to LSG in subjects with obesity and T2D. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the mechanism and preoperative factors related to this amelioration have been uncertain. This study investigated the effect of laparoscopic sleeve gastrectomy (LSG) on beta-cell function. The preoperative characteristics and factors associated with the degree of postoperative changes in beta-cell function in those subjects were explored as well. In this subanalysis of our prospective observational study, subjects with obesity and T2D underwent oral glucose tolerance tests (OGTTs) and magnetic resonance imaging (MRI), at the baseline and the end of the 1-year follow-up period. Beta-cell function was evaluated by the insulin secretion-sensitivity index-2 (ISSI-2) and disposition index (DI), and the preoperative factors associated with these changes were examined. In 18 eligible subjects, glucose tolerance improved, ISSI-2 increased significantly, and DI also tended to increase 1 year after LSG. The change in ISSI-2 correlated with preoperative liver fibrosis assessed by MR elastography ( = -0.49, < 0.05). In 16 subjects without severe fibrosis, changes in DI correlated with preoperative MRI-estimated proton density fat fraction ( = -0.52, < 0.05). Neither as glycemic control nor visceral fat was significantly associated with the degree of amelioration in beta-cell function. Pancreatic beta-cell function improved at 1-year postoperative to LSG in subjects with obesity and T2D. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent laparoscopic sleeve gastrectomy. Preoperative liver fibrosis and steatosis were associated with a lower degree of postoperative pancreatic beta-cell improvement. Considering that amelioration of pancreatic beta-cell function leads to better outcome of T2D, the finding of this association would be clinically significant. |
Author | Takase, Takahiro Kudo, Kohsuke Nakamura, Akinobu Kameda, Hiraku Cho, Kyu Yong Sakamoto, Naoya Oe, Yuki Ebihara, Yuma Yoshikawa, Masato Atsumi, Tatsuya Ogawa, Koji Nomoto, Hiroshi Suda, Goki Hirano, Satoshi Miya, Aika |
Author_xml | – sequence: 1 givenname: Yuki orcidid: 0000-0002-4947-5395 surname: Oe fullname: Oe, Yuki – sequence: 2 givenname: Akinobu orcidid: 0000-0002-8192-0006 surname: Nakamura fullname: Nakamura, Akinobu – sequence: 3 givenname: Kyu Yong surname: Cho fullname: Cho, Kyu Yong – sequence: 4 givenname: Takahiro surname: Takase fullname: Takase, Takahiro – sequence: 5 givenname: Koji surname: Ogawa fullname: Ogawa, Koji – sequence: 6 givenname: Yuma surname: Ebihara fullname: Ebihara, Yuma – sequence: 7 givenname: Masato surname: Yoshikawa fullname: Yoshikawa, Masato – sequence: 8 givenname: Aika surname: Miya fullname: Miya, Aika – sequence: 9 givenname: Hiroshi surname: Nomoto fullname: Nomoto, Hiroshi – sequence: 10 givenname: Hiraku surname: Kameda fullname: Kameda, Hiraku – sequence: 11 givenname: Goki surname: Suda fullname: Suda, Goki – sequence: 12 givenname: Kohsuke surname: Kudo fullname: Kudo, Kohsuke – sequence: 13 givenname: Naoya surname: Sakamoto fullname: Sakamoto, Naoya – sequence: 14 givenname: Satoshi surname: Hirano fullname: Hirano, Satoshi – sequence: 15 givenname: Tatsuya surname: Atsumi fullname: Atsumi, Tatsuya |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40376712$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkc9O4zAQxq1V0baw-wJ7QJa4cEnx3zg5Vt3lj1TBBc6Ra49XrZI42A4rXmsfhGfCgcKB08zo-2k033zHaNb7HhD6RcmSUsku9H6A3volIaISS0aY-IYWWWAFlVLO0ILQmhe0EvUcHce4J4QoKdh3NBeEq1JRtkD_brpBm4S9w0MAP0DQafcE-HZ1ufmNY9JpjNj3OEBMftJyP7G6NwHyaPDL_8JA22I39uZN1i5BwK0edPDR-CEzsQXIS__qmAKY5LvnH-jI6TbCz0M9QQ-Xf-7X18Xm7upmvdoUhskyFVST7EUZZ0RJlKLEiK2TlbRClsxmayUllnJem6pyWjsnpLWCq63YgrVS8RN0_r53CP5xzCaabhene3UPfowNZ0QoIZkqM3r2Bd37MfT5ukwxXpeM1jJTpwdq3HZgmyHsOh2em4-XZoC9AybbjwHcJ0JJM-XWHHJr3nJrptz4K0R-jdA |
Cites_doi | 10.2337/diab.26.10.944 10.1001/jama.2014.5988 10.1016/j.soard.2014.06.019 10.1111/liv.12912 10.1016/j.amjmed.2009.03.015 10.1007/s00535-012-0533-z 10.1210/jc.2013-2538 10.2337/dc20-0150 10.1007/s00125-017-4513-y 10.3389/fmed.2022.894465 10.1210/jcem.85.7.6661 10.1007/BF00280883 10.2337/dc16-0382 10.1007/s00125-017-4385-1 10.14218/JCTH.2022.00085 10.1507/endocrj.k07-016 10.1038/s41598-021-83871-0 10.2337/dc08-1762 10.1002/jgh3.12367 10.1016/S0140-6736(09)60619-X 10.2337/db22-0056 10.1111/dme.13199 10.1038/s41467-021-25423-8 10.1530/EJE-12-0605 10.1210/jc.2011-0446 10.1111/j.1440-1746.1998.tb00714.x 10.2337/dc22-S002 10.1056/NEJMoa1600869 10.1210/er.2018-00183 10.2337/db22-1424-P 10.1210/clinem/dgac446 10.2337/diacare.22.9.1462 10.3389/fendo.2023.1031610 10.2337/dc17-1902 10.1016/j.cgh.2020.06.032 10.1016/j.diabres.2019.107843 10.1053/j.gastro.2016.10.026 10.1097/SLA.0b013e3182a5034b 10.1111/jdi.13221 10.1507/endocrj.EJ23-0403 10.3389/fendo.2019.00641 10.1016/j.cgh.2018.05.059 10.1002/hep.1840200104 10.1210/clinem/dgaa435 |
ContentType | Journal Article |
Copyright | Copyright American Physiological Society 2025 |
Copyright_xml | – notice: Copyright American Physiological Society 2025 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7TS 7U7 C1K 7X8 |
DOI | 10.1152/ajpendo.00484.2024 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Physical Education Index Toxicology Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Toxicology Abstracts Calcium & Calcified Tissue Abstracts Physical Education Index Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic Toxicology Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1522-1555 |
EndPage | E1020 |
ExternalDocumentID | 40376712 10_1152_ajpendo_00484_2024 |
Genre | Journal Article Observational Study |
GroupedDBID | --- 23M 39C 4.4 5GY 6J9 AAYXX ABJNI ACPRK ADBBV AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BKKCC BKOMP BTFSW CITATION E3Z EBS EMOBN F5P H13 ITBOX KQ8 OK1 P2P P6G PQQKQ RAP RHI RPL RPRKH TR2 WH7 WOQ XSW YSK CGR CUY CVF ECM EIF NPM 7QP 7TS 7U7 C1K 7X8 |
ID | FETCH-LOGICAL-c256t-1a01557cfc4607710c4bf585d4562d184610d1339c88faaff45dd437b4bedd573 |
ISSN | 0193-1849 1522-1555 |
IngestDate | Wed Jul 02 03:48:44 EDT 2025 Mon Jun 30 07:16:57 EDT 2025 Thu Jun 19 02:15:48 EDT 2025 Thu Jul 03 08:13:58 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | magnetic resonance imaging nonalcoholic fatty liver disease bariatric surgery pancreatic beta cells type 2 diabetes |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c256t-1a01557cfc4607710c4bf585d4562d184610d1339c88faaff45dd437b4bedd573 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-8192-0006 0000-0002-4947-5395 |
OpenAccessLink | https://journals.physiology.org/doi/pdf/10.1152/ajpendo.00484.2024 |
PMID | 40376712 |
PQID | 3223962195 |
PQPubID | 48583 |
ParticipantIDs | proquest_miscellaneous_3204745276 proquest_journals_3223962195 pubmed_primary_40376712 crossref_primary_10_1152_ajpendo_00484_2024 |
PublicationCentury | 2000 |
PublicationDate | 2025-Jun-01 |
PublicationDateYYYYMMDD | 2025-06-01 |
PublicationDate_xml | – month: 06 year: 2025 text: 2025-Jun-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Bethesda |
PublicationTitle | American journal of physiology: endocrinology and metabolism |
PublicationTitleAlternate | Am J Physiol Endocrinol Metab |
PublicationYear | 2025 |
Publisher | American Physiological Society |
Publisher_xml | – name: American Physiological Society |
References | B20 B42 B21 B43 B22 B44 B23 B24 B25 B26 B27 B28 B29 B30 B31 B10 B32 B11 B33 B12 B34 B13 B35 B14 B36 B15 B37 B16 B38 B17 B39 B18 B19 B1 B2 B3 B4 B5 B6 B7 B8 B9 B40 B41 |
References_xml | – ident: B18 doi: 10.2337/diab.26.10.944 – ident: B24 doi: 10.1001/jama.2014.5988 – ident: B26 doi: 10.1016/j.soard.2014.06.019 – ident: B29 doi: 10.1111/liv.12912 – ident: B3 doi: 10.1016/j.amjmed.2009.03.015 – ident: B27 doi: 10.1007/s00535-012-0533-z – ident: B10 doi: 10.1210/jc.2013-2538 – ident: B42 doi: 10.2337/dc20-0150 – ident: B7 doi: 10.1007/s00125-017-4513-y – ident: B41 doi: 10.3389/fmed.2022.894465 – ident: B15 doi: 10.1210/jcem.85.7.6661 – ident: B17 doi: 10.1007/BF00280883 – ident: B5 doi: 10.2337/dc16-0382 – ident: B34 doi: 10.1007/s00125-017-4385-1 – ident: B38 doi: 10.14218/JCTH.2022.00085 – ident: B20 doi: 10.1507/endocrj.k07-016 – ident: B40 doi: 10.1038/s41598-021-83871-0 – ident: B8 doi: 10.2337/dc08-1762 – ident: B37 doi: 10.1002/jgh3.12367 – ident: B4 doi: 10.1016/S0140-6736(09)60619-X – ident: B35 doi: 10.2337/db22-0056 – ident: B19 doi: 10.1111/dme.13199 – ident: B13 doi: 10.1038/s41467-021-25423-8 – ident: B31 doi: 10.1530/EJE-12-0605 – ident: B9 doi: 10.1210/jc.2011-0446 – ident: B36 doi: 10.1111/j.1440-1746.1998.tb00714.x – ident: B2 doi: 10.2337/dc22-S002 – ident: B6 doi: 10.1056/NEJMoa1600869 – ident: B11 doi: 10.1210/er.2018-00183 – ident: B14 doi: 10.2337/db22-1424-P – ident: B22 doi: 10.1210/clinem/dgac446 – ident: B16 doi: 10.2337/diacare.22.9.1462 – ident: B23 doi: 10.3389/fendo.2023.1031610 – ident: B28 doi: 10.2337/dc17-1902 – ident: B30 doi: 10.1016/j.cgh.2020.06.032 – ident: B1 doi: 10.1016/j.diabres.2019.107843 – ident: B43 doi: 10.1053/j.gastro.2016.10.026 – ident: B25 doi: 10.1097/SLA.0b013e3182a5034b – ident: B32 doi: 10.1111/jdi.13221 – ident: B33 doi: 10.1507/endocrj.EJ23-0403 – ident: B12 doi: 10.3389/fendo.2019.00641 – ident: B44 doi: 10.1016/j.cgh.2018.05.059 – ident: B21 doi: 10.1002/hep.1840200104 – ident: B39 doi: 10.1210/clinem/dgaa435 |
SSID | ssj0007542 |
Score | 2.4718952 |
Snippet | In the present study, pancreatic beta-cell function improved at 1 year postoperatively in subjects with obesity and type 2 diabetes (T2D) who underwent... Although pancreatic beta-cell insufficiency is ameliorated after bariatric and metabolic surgery in subjects with obesity and type 2 diabetes (T2D), the... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database |
StartPage | E1013 |
SubjectTerms | Adult Bariatric Surgery Beta cells Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - metabolism Diabetes Mellitus, Type 2 - physiopathology Diabetes Mellitus, Type 2 - surgery Fatty liver Female Fibrosis Gastrectomy Gastrectomy - methods Gastrointestinal surgery Glucose Glucose tolerance Glucose Tolerance Test Humans Insulin Resistance Insulin secretion Insulin-Secreting Cells - metabolism Insulin-Secreting Cells - physiology Laparoscopy Liver Liver cirrhosis Magnetic Resonance Imaging Male Middle Aged Non-alcoholic Fatty Liver Disease - complications Non-alcoholic Fatty Liver Disease - physiopathology Non-alcoholic Fatty Liver Disease - surgery Obesity Obesity - complications Obesity - surgery Obesity, Morbid - complications Obesity, Morbid - surgery Observational studies Pancreas Preoperative Period Prospective Studies Proton density (concentration) Sleeves Steatosis Treatment Outcome |
Title | Impact of preoperative NAFLD status on restoration of pancreatic β-cell function after laparoscopic sleeve gastrectomy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40376712 https://www.proquest.com/docview/3223962195 https://www.proquest.com/docview/3204745276 |
Volume | 328 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAvCDYuhYGMxHipMprYzuVxjE6DsQmkTdqeIjtxYLRLqi4Rgp_FD-Gdf8M5dpJ6sEmMlyhNEzfN-XIun33OIeSFBpMV-lJ5CfgDHs-jzIuVX3iM60hBOJGwBPOd9w_C3SP-7lgcDwa_nFVLTa02s--X5pX8j1ThGMgVs2SvIdl-UDgA-yBf2IKEYftPMn7bpzjOF7qa67aK98HWzvs3SBLUjZkMWJjuMb1vCO-_dRWz0cb2ZON14CF7P0IL57QNn4EVxUqX1RzOO59pDQN_kphaktVdGkRXvbab9XHKUBjGxGbCYO-fMq9APZXLgk9nugb4zboChkjzGmr1pJme9gS1nMqzZmGZ3ylcrZrlagRD8e59a0YnVWt8Df8wlbZTJO59Pl1ULqsRiOXqq47oTJgH0adVp7pVzhA4g_8jXO3NgtiBqauLJ6BtmGPY4bPJu7vEagisQiu_YNfhahOVGrJtNrf7YonuP0xnv6DRhFIiSNsxUjNGimPcIDcDiGCwucbex2Uhe2w8bDP57d_s8rlE8Orv-7joM10RCBmH6PAuudNGMnTLwvIeGehylaxtlRLhQV_SDz0CVsmt_XYJxxr5akFLq4K6oKUGtNSCllYldUBrzu1BS3_-MIClHWCpASx1AUstYKkD2PvkaGdyuL3rtd0_vAzc8NrzJbrzUVZkPBxH4AhnXBUQ3OYYs-fwzMDxz33GkiyOCymLgos85yxSXOk8FxF7QFbKqtSPCOWFynGCXepQwtVRXGihY6Z8XohE6GRIRt3zTee2yEt6tUSHZL0TQdq-V-cp2EWWhGD-xZA8778GVY0PRJa6avCcMY-4CKJwSB5a0fU_x8dYVskPHl_rVp6Q28uXZ52s1ItGPwUnuVbPDNx-A_KSwaw |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+preoperative+NAFLD+status+on+restoration+of+pancreatic+%CE%B2-cell+function+after+laparoscopic+sleeve+gastrectomy&rft.jtitle=American+journal+of+physiology%3A+endocrinology+and+metabolism&rft.au=Oe%2C+Yuki&rft.au=Nakamura%2C+Akinobu&rft.au=Cho%2C+Kyu+Yong&rft.au=Takase%2C+Takahiro&rft.date=2025-06-01&rft.issn=0193-1849&rft.eissn=1522-1555&rft.volume=328&rft.issue=6&rft.spage=E1013&rft.epage=E1020&rft_id=info:doi/10.1152%2Fajpendo.00484.2024&rft.externalDBID=n%2Fa&rft.externalDocID=10_1152_ajpendo_00484_2024 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0193-1849&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0193-1849&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0193-1849&client=summon |